LINC00152 knock-down suppresses esophageal cancer by EGFR signaling pathway

Affiliations

Ding Yan: Department of Oncology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing210019, China
Guo Hai: Department of Internal Medicine, Huai’an First People’s Hospital, Huai’an223300, Jiangsu Province, China
Zhu Liangjun: Department of Internal Medicine, Jiangsu Provincal Tumor Hospital, Nanjing210009, Jiangsu Province, China
Xu Li: Nanjing University of Chinese Medicine, Nanjing210046, Jiangsu Province, China
Pei Qingyu: Department of Orthopaedics, Nanjing Yuhua Hospital, Nanjing210000, Jiangsu Province, China
Cao Youjun: Department of Oncology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing210019, China

Abstract

This study aims to explain the role and mechanism of lncRNA LINC00152 in esophageal cancer.